NKGen Biotech, Inc. Warrants

NKGen Biotech, Inc. operates as a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies. It offers an autologous NK cell therapy candidate. NKGen Biotech, Inc. was formerly known as NKMAX America, Inc. and changed its name to NKGen Biotech, Inc. in February 2021. The company was founded in 2017 and is based in Santa Ana, California with an additional office in Irvine, California. NKGen Biotech, Inc. operates as a subsidiary of NKMAX Co.,Ltd. Show More...